IL-17 axis activation and Th17/Treg cellular imbalance were previously reported to play a central role in the progression from NAFL to NASH in both mice and patients with NAFLD (11, 13, 30). Here, IL17A is linked to metabolic dysfunction-associated steatohepatitis.